Advertisement
Home »

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).

Mar 20, 2023

ABOUT THE EXPERTS

  • Robert Seifert

    Department of Nuclear Medicine, University Hospital Essen, Essen, Germany. Electronic address: robert.seifert@uk-essen.de.

    Louise Emmett

    Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, NSW, Australia.

    Steven P Rowe

    The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins, University School of Medicine, Baltimore, MD, USA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Ken Herrmann

    Department of Nuclear Medicine, University Hospital Essen, Essen, Germany; Ahmanson Translational Theranostics, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, CA, USA.

    Boris Hadaschik

    Department of Urology, University Hospital Essen, Essen, Germany.

    Jeremie Calais

    Ahmanson Translational Theranostics, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, CA, USA.

    Frederik L Giesel

    Department of Nuclear Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.

    Robert Reiter

    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

    Tobias Maurer

    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

    Matthias Heck

    Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.

    Andrei Gafita

    Ahmanson Translational Theranostics, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, CA, USA.

    Michael J Morris

    Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

    Stefano Fanti

    IRCCS AOU di Bologna, Bologna, Italy.

    Wolfgang A Weber

    Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

    Thomas A Hope

    Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.

    Michael S Hofman

    Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.

    Wolfgang Peter Fendler

    Department of Nuclear Medicine, University Hospital Essen, Essen, Germany; PET Committee of the German Society of Nuclear Medicine, Göttingen, Germany.

    Matthias Eiber

    Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement